In this direction, interestingly, a recent study on multivariate GWAS in Alzheimer’s disease that investigated the role of genetic variants on CSF biomarker profiles showed a genome-wide significant gene-based association with variants in GRIN2D and the synaptic functioning components, further supporting a role of altered synaptic function in AD [48]. This evidence concerns the gene GRIN2D and Alzheimer disease.